(HealthDay)—Time to treatment initiation (TTI) is rising for patients with head and neck squamous cell carcinoma, according to a study published online Dec. 9 in Cancer.
Jan 7, 2015
0
5
(HealthDay)—Helicobacter pylori may not be a risk factor for head and neck squamous cell carcinoma, according to a study published online Dec. 18 in Head & Neck.
Dec 30, 2014
0
0
Induced pluripotent stem cells made from patients with a form of blistering skin disease can be genetically corrected and used to grow back healthy skin cells in laboratory dishes, researchers at the Stanford University School ...
Nov 26, 2014
0
0
The expression of SIP1 protein in pharyngeal squamous cell carcinoma tumours often indicates an advanced tumour stage, a high risk of recurrence and a poor prognosis, according to research from the University of Eastern Finland. ...
Nov 14, 2014
0
0
A better survival outcome is associated with low blood levels of squamous cell carcinoma antigen, or absence of tumor invasion either into the space between the lungs and chest wall or into blood vessels of individuals with ...
Oct 24, 2014
0
0
A study recently published in the Journal of the American Academy of Dermatology shows that for Ebola, measles, syphilis and many other conditions with skin manifestations the mortality rates are hundreds of times higher ...
Oct 16, 2014
0
0
The study, from the International Agency for Research on Cancer (IARC), the specialist cancer agency of the World Health Organization, is the first to try and quantify the worldwide extent of each of the two main types of ...
Oct 16, 2014
0
0
(Medical Xpress)—New research on an enzyme linked to cancer development shows that 37 percent of mice that produce excessive quantities of the enzyme developed skin tumors within four to 12 months of birth, and many of ...
Sep 23, 2014
0
0
Patients with a recurrence of head and neck cancer who have previously received radiation treatment can be treated more quickly, safely and with fewer side effects with high doses of targeted radiation known as Stereotactic ...
Sep 17, 2014
0
0
A blood test may be beneficial in indicating neoadjuvant treatment regimens for patients with esophageal squamous cell carcinoma (ESCC), according to research presented today at the American Society for Radiation Oncology's ...
Sep 15, 2014
0
0
